Alvine Pharma Raises $21.5 Million
Alvine Pharmaceuticals Inc., a San Carlos, Calif.-based developer of therapeutics for autoimmune and gastrointestinal diseases, has raised $21.5 million in additional Series A funding. The round now stands at around $47.5 million. Panorama Capital led the expansion tranche, and was joined by return backers InterWest Partners, Prospect Venture Partners, Sofinnova Ventures, Black River Asset Management and Flagship Ventures.
15 September 2009•3 mins read
